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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER2455Acute Aortic DissectionRobert S. Bonser, Aaron M. Ranasinghe, Mahmoud Loubani, Jonathan D. Evans, Nassir M. A. Thalji,
Jean E. Bachet, Thierry P. Carrel, Martin Czerny, Roberto Di Bartolomeo, Martin Grabenwoger, Lars Lonn,
Carlos A. Mestres, Marc A. A. M. Schepens, Ernst Weigang
Acute type aortic dissection requires rapid diagnosis and treatment. Although imaging-based
diagnostic accuracy is excellent, the diagnosis is commonly delayed as other etiologies for
chest pain or malperfusion are sought or treated. Patient selection for medical treatment
should be based upon a comprehensive appreciation of risk factors including age 70 years;
history of aortic valve replacement; presentation with hypotension, shock or tamponade;
migrating chest pain; and any pulse deficit, and not on a single factor alone. In a comprehensive
review, Bonser and colleagues conclude by advocating for research into pre-hospital diagnostic
recognition and establishment of designated specialist units to facilitate all management.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
2475Percutaneous MV Replacement May Be Possible
in Patients With a Previous Mitral Annuloplasty RingTakashi Shuto, Norihiro Kondo, Yoav Dori, Kevin J. Koomalsingh, Andrew C. Glatz, Jonathan J. Rome,
Joseph H. Gorman III, Robert C. Gorman, Matthew J. Gillespie
Percutaneous replacement of the mitral valve (MV) is not currently possible due to anatomic
features of the MV that make fixation and perivalvular seal devices a challenge. Shuto and
associates hypothesized that a previously placed mitral annuloplasty ring may provide the
necessary support and tested this in a sheep model. Five sheep underwent surgical MV
annuloplasty, then 1 week later, underwent valve-in-ring (VIR) implantation with a Melody
valve via a transfemoral venous, transatrial septal approach. VIR was technically successful in
all animals. Fluoroscopy and echocardiography demonstrated securely positioned valves within
the annuloplasty ring, most with no significant MV regurgitation, no outflow tract
obstruction, and no aortic valve insufficiency. This study suggests the feasibility of a purely
percutaneous approach to MV replacement in patients with pre-existing annuloplasty rings.(continued on page A-26)
DECEMBER 6, 2011 (continued) A-26ATHEROSCLEROSIS2481Defective HDL-Cholesterol Linked to AtherosclerosisRaphaël Duivenvoorden, Adriaan G. Holleboom, Bas van den Bogaard, Aart J. Nederveen, Eric de Groot,
Barbara A. Hutten, Alinda W. Schimmel, G. Kees Hovingh, John J. P. Kastelein, Jan Albert Kuivenhoven,
Erik S. G. Stroes
A crucial enzyme in high-density lipoprotein (HDL) metabolism is lecithin:cholesterol acyl
transferase (LCAT) which esterifies free cholesterol using apolipoprotein A-I (apoA-I) as a
cofactor. Duivenvoorden and colleagues investigated the role of reduced LCAT function on
atherogenesis by studing heterozygous LCAT mutation carriers for carotid atherosclerosis
using carotid magnetic resonance imaging and B-mode ultrasound. Carriers had 31% lower
LCAT activity levels and 38% decreased HDL-cholesterol levels, which was associated with a
10% higher normalized wall index, a 22% higher mean wall area, and a 22% higher total wall
volume compared to controls. These findings imply that raising LCAT activity may be an
attractive target in cardiovascular prevention strategies.Editorial Comment: Sergio Fazio, MacRae F. Linton, page 2488HEART RHYTHM DISORDERS2491Post-Infarction VT Often Involves the Interventricular SeptumKentaro Yoshida, Miki Yokokawa, Benoit Desjardins, Eric Good, Hakan Oral, Aman Chugh, Frank Pelosi,
Fred Morady, Frank Bogun
Yoshida and colleagues reviewed consecutive patients with recurrent post-infarction ventricular
tachycardia (VT) referred for ablation to determine how often the re-entry circuit involved
the interventricular septum. Forty-five percent of patients were identified in whom the critical
part of the VT involved the interventricular septum. The critical component of the re-entry
circuit was usually confined to the endocardium, but occasionally involved the Purkinje system
or an intramural area. All VTs mapped to the interventricular septum were acutely
successfully ablated. Post-infarction VT involving the interventricular septum appears to be
common and treatable with ablation.CARDIOMYOPATHY
2501Radiofrequency Ablation May Be Able
to Relieve the Obstruction in Patients With HOCMNarayanswami Sreeram, Mathias Emmel, Joseph V. de Giovanni
Sreeram and colleagues report on their use of radiofrequency catheter septal reduction
(RFCA) in the treatment of hypertrophic obstructive cardiomyopathy (HOCM) in children.
In 32 children, at a median age of 11 years, ablation of the hypertrophied septum was
performed using a cool-tip ablation catheter via a femoral approach. The majority of patients
demonstrated an immediate decrease in the catheter pullback gradient (from a mean of 78 to
36 mm Hg post-RFCA). One patient died due to a paradoxical increase in left ventricular
outflow tract obstructions due to tissue edema, and another had persistent atrioventricular
block requiring permanent pacing. These preliminary results of RFCA for septal reduction are
promising, and merit further evaluation.
(continued on page A-31)
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EPULMONARY HYPERTENSION2511Mortality in Patients With PAH Linked More Closely to RVEF Than PVR0 25 50 75 100 125
1. RVEF > 35, PVR < 650 (n = 36)
3. RVEF < 35, PVR < 650 (n = 13)
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Time, monthsMariëlle C. van de Veerdonk, Taco Kind, J. Tim Marcus, Gert-Jan Mauritz, Martijn W. Heymans,
Harm-Jan Bogaard, Anco Boonstra, Koen M. J. Marques, Nico Westerhof, Anton Vonk-Noordegraaf
van de Veerdonk and colleages studied the relationship between changes in pulmonary
vascular resistance (PVR), right ventricular ejection fraction (RVEF), and survival in
pulmonary arterial hypertension (PAH) patients. A cohort of 110 incident PAH patients
underwent baseline right heart catheterization, cardiac magnetic resonance imaging, and 6-
min walk testing. These measurements were repeated after 12 months of therapy. Baseline
RVEF and PVR were predictors of mortality during the subsequent 12 months and 5 years.
In two-thirds of the patients, PVR decreased after medical therapy, but one-quarter of these
showed a deterioration of right ventricular function and had a poor prognosis. RVEF
measured at baseline was a better predictor of mortality than PVR and changes in RVEF
after 1 year was a better predictor of long-term outcomes than changes in PVR.Editorial Comment: Reda E. Girgis, page 2520PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH2522MRI of a Mouse Model of AAAAhmed Klink, Joeri Heynens, Beatriz Herranz, Mark E. Lobatto, Teresa Arias, Honorius M. H. F. Sanders,
Gustav J. Strijkers, Maarten Merkx, Klaas Nicolay, Valentin Fuster, Alain Tedgui, Ziad Mallat,
Willem J. M. Mulder, Zahi A. Fayad
Klink and colleagues used a mouse model where a combination of angiotensin-II infusion
and transforming growth factor- neutralization results in abdominal aortic aneurysm (AAA)
ormation with a high incidence of aortic rupture. High-resolution multi-sequence magnetic
esonance imaging (MRI) was performed to characterize the temporal progression of the
AA and paramagnetic/fluorescent micellar nanoparticles functionalized with a collagen-
inding protein (CNA-35) were used to visualize the location of collagen in the AAA.
nitially, there was a primary fibrotic response in the aortic wall, followed by the formation of
secondary channel or dissection with a dramatic increase of the aortic diameter. Injection of
NA-35 micelles resulted in magnetic resonance signal enhancement in the aneurysmal wall
nd was confirmed to identify collagen on tissue analyses. This model and imaging technique
llows longitudinal monitoring of AAA progression, and for the role of collagen in the
rocess to be studied.
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Mouaz Al-Mallah, Daniel S. Berman, Matthew J. Budoff, Filippo Cademartiri, Tracy Q. Callister,
Hyuk-Jae Chang, Victor Y. Cheng, Kavitha Chinnaiyan, Benjamin J. W. Chow, Augustin Delago,
Martin Hadamitzky, Jörg Hausleiter, Philipp Kaufmann, Fay Y. Lin, Erica Maffei, Gilbert L. Raff,
James K. Min, for the CONFIRM Registry Investigators
Villines and colleagues used data from the CONFIRM (Coronary CT Angiography
Evaluation for Clinical Outcomes: An International Multicenter) registry to determine the
prevalence and severity of coronary artery disease (CAD) and the medium-term prognosis in
symptomatic patients with a coronary artery calcification (CAC) score of 0. Over 10,000
subjects underwent coronary computed tomography angiography (CCTA) in addition to
CAC determination. One-half of subjects had a CAC score of 0. Among those subjects with
a CAC score of 0, 84% had no CAD, 3.5% had 50% stenosis, and 1.4% had 70%
stenosis on CCTA. During a median follow-up of 2.1 years, 3.9% of subjects with a CAC
score of 0 and 50% stenosis experienced a cardiac event compared with 0.8% of subjects
with a CAC score of 0 and no obstructive CAD (hazard ratio: 5.7). These results show that
CCTA offers additional prognostic information even when subjects have a CAC score of 0.
